Effective lowering of plasma, LDL, and esterified cholesterol in LDL receptor-knockout mice by adenovirus-mediated gene delivery of ApoB mRNA editing enzyme (Apobec1)

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 5, 1997, Pages 889-897

  Teng, Babie ^a   Ishida, Brian ^b   Forte, Trudy M ^c   Blumenthal, Scott ^a   Song, Li Zhen ^a   Gotto Jr , Antonio M ^a   Chan, Lawrence ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

apoB mRNA editing; gene therapy; hypercholesterolemia; LDL receptor deficient mouse; lipoproteins

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; VIRUS VECTOR;

ADENOVIRUS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS RECOMBINANT;

EID: 0030994487     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.5.889     Document Type: Article

References (32)

1. Kane JP. Apolipoprotein B: structural and metabolic heterogeneity. Annu Rev Physiol. 1983;45:637-650. Review.
2. Chan L. Apolipoprotein B, the major protein component of triglyceride-rich and low density lipoproteins. J Biol Chem. 1992;267:25621-25624.
3. Powell LM, Wallis SC, Pease RJ, Edwards YH, Knott TJ, Scott J. A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine. Cell. 1987:50:831-840.
4. Chen SH, Habib G, Yang CY, Gu ZW, Lee BR, Weng SA, Silberman SR, Cai SJ, Deslypere JP, Rosseneu M, Gotto AM Jr, Li W-H, Chan L. Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science. 1987;238:363-366.
5. Marsh JB, Sparks CE. The effect of fasting on the secretion of lipoproteins and two forms of apoB by perfused rat liver. Proc Soc Exp Biol Med. 1982;170:178-181.
6. Swift LL. Assembly of very low density Iipoproteins in rat liver: a study of nascent particles recovered from the rough endoplasmic reticulum. J Lipid Res. 1995;36:395-406.
7. Yao Z, McLeod RS. Synthesis and secretion of hepatic apolipoprotein B-containing lipoproteins. Biochim Biophys Acta. 1994; 1212:152-166.
8. Jackson TK, Salhanick AI, Elovson J, Diechman ML, Amatruda JM. Insulin regulates apolipoprotein B turnover and phosphorylation in rat hepatocytes. J Clin Invest. 1990;86:1746-1751.
9. Borchardt RA, Davis RA. Intrahepatic assembly of very low density lipoproteins: rate of transport out of the endoplasmic reticulum determines rate of secretion. J Biol Chem. 1987;262:16394-16402.
10. Swift LL, Padley RJ, Getz GS. Differential labeling of rat hepatic Golgi and serum very low density lipoprotein apoprotein B variants. J Lipid Res. 1987;28:207-215.
11. Young SG. Recent progress in understanding apolipoprotein B. Circulation. 1990;82:1574-1594.
12. Teng BB, Burant CF, Davidson NO. Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science. 1993; 260:1816-1819.
13. Davidson NO, Innerarity TL, Scott J, Smith H, Driscoll DM, Teng BB, Chan L. Proposed nomenclature for the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme: APOBEC-1. RNA. 1995;1:3. Letter.
14. Smith HC, Kuo S-R, Backus JW, Harris SG, Sparks CE, Sparks JD. In vitro apolipoprotein B mRNA editing: identification of a 278 editing complex. Proc Natl Acad Sci U S A. 1991;88:1489-1493.
15. Navaratnam N, Morrison JR, Bhattacharya S. Patel D, Funahashi T, Giannoni F, Teng BB, Davidson NO, Scott J. The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase. J Biol Chem. 1993;268:20709-20712.
16. Navaratnam N, Bhattacharya S, Fujino T, Patel D, Jarmuz AL, Scott J. Evolutionary origins of apoB mRNA editing: catalysis by a cytidine deaminase that has acquired a novel RNA-binding motif at its active site. Cell. 1995;81:187-195.
17. Giannoni F, Bonen DK, Funahashi T, Hadjiagapiou C, Burant CF, Davidson NO. Complementation of apolipoprotein B mRNA editing by human liver accompanied by secretion of apolipoprotein B-48. J Biol Chem. 1994;269:5932-5936.
18. Teng BB, Blumenthal S, Forte T, Navaratnam N, Scott J, Gotto AM Jr, Chan L. Adenovirus-mediated gene transfer of rat apolipoprotein B mRNA-editing protein in mice virtually eliminates apolipoprotein B-100 and normal low density lipoprotein production. J Biol Chem. 1994;269:29395-29408.
19. Hughes SD, Rouy D, Navaratnam N, Scott J, Rubin EM. Gene transfer of cytidine deaminase apobec-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits. Hum Gene Ther. 1996;7:39-49.
20. Yamanaka S, Baestra ME, Ferrell LD, Fan J, Arnold KS, Taylor S, Taylor JM, Innerarity TL. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc Natl Acad Sci U S A. 1995;92:8483-8487.
21. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-meditated gene delivery. J Clin Invest. 1993;92:883-893.
22. Bell GI, Karam JH, Rutter WJ. Polymorphic DNA region adjacent to the 5′ end of the human insulin gene. Proc Natl Acad Sci U S A. 1981;78:5759-5763.
23. Baum CL, Teng BB, Davidson NO. Apolipoprotein B mRNA editing in the rat liver: modulation by fasting and refeeding a high carbohydrate diet. J Biol Chem. 1990;265:19263-19270.
24. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
25. Teng BB, Davidson NO. Evolution of intestinal apolipoprotein B mRNA editing chicken apolipoprotein B mRNA is not edited, but chicken enterocytes contain in vitro editing enhancement factor(s). J Biol Chem. 1992;267:21265-21272.
26. Ishida BY, Paigen B. Silver-enhanced radial immunodiffusion assay of plasma apolipoproteins. J Lipid Res. 1992;33:1073-1078.
27. Kobayashi K, Oka K, Forte T, Ishida B, Teng BB, Ishimura-Oka K, Nakamuta M, Chan L. Reversal of hypercholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor. J Biol Chem. 1996;271:6852-6860.
28. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1345-1353.
29. Nichols AV, Krauss RM, Musliner TA. Nondenaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol. 1986;128: 417-431.
30. Inui Y, Hausman AML, Nanthakumar N, Henning SJ, Davidson NO. Apolipoprotein B messenger RNA editing in rat liver: developmental and hormonal modulation is divergent from apolipoprotein A-IV gene expression despite increased hepatic lipogenesis. J Lipid Res. 1992;33:1843-1856.
31. Sniderman AD, Cianflone K. Substrate delivery as a determinant of hepatic apoB secretion. Arterioscler Thromb. 1993;13:629-636.
32. Teng BB, Thompson GR, Sniderman AD, Forte TM, Krauss RM, Kwiterovich PO Jr. Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia normolipidemia and familial hypercholesterolemia. Proc Natl Acad Sci U S A. 1983;80:6662-6666.